An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia

Stem Cell Res. 2021 Mar:51:102166. doi: 10.1016/j.scr.2021.102166. Epub 2021 Jan 9.

Abstract

Cleidocranial dysplasia (CCD; MIM #119600) is an autosomal dominant genetic disorder caused by heterozygous loss-of-function mutation of the RUNX2 gene, which is important in the differentiation of osteoblasts and maturation of chondrocytes. In this study, we generated an induced pluripotent stem cell line GZHMCi003-A derived from umbilical cord blood mononuclear cells (UCBMCs) of a fetus with heterozygous deletion of the exon 3 in RUNX2 gene. This iPSC line is an ideal in vitro model to study the pathological mechanism and the treatment of CCD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cleidocranial Dysplasia* / genetics
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Exons / genetics
  • Fetus
  • Humans
  • Induced Pluripotent Stem Cells*

Substances

  • Core Binding Factor Alpha 1 Subunit
  • RUNX2 protein, human